ALR Technologies Announces Remote Insulin Dosing Consultations by World-Renowned Diabetologist
15 Juillet 2014 - 8:22PM
InvestorsHub NewsWire
Richmond, VA, July 15, 2014 – ALR Technologies (OTCQB:
ALRT) a medical device company providing remote monitoring and
care facilitation for patients with chronic diseases, announces
today that online consultations for its new Insulin Dose Adjustment
Consultation System (IDAC) will be provided by the endocrinology
practice of Dr. Mayer B. Davidson, one of the world’s leading
experts on diabetes and insulin.
ALRT had announced the details of its new IDAC system in a news release on May 7,
2014.
Dr. Davidson’s endocrinology practice will provide the dosing
opinion based on review of actual blood glucose data, provided
electronically by ALRT’s Health-e-Connect System, along with other
key data that is necessary for prescribing, such as current insulin
dosage, gender, height and weight.
The IDAC system is designed to assist Primary Care Physicians
(PCPs) in maintaining patients at an optimal insulin dose,
stabilizing A1c levels and potentially reducing complications and
related costs of treatment. In addition, a readily available
endocrinology consult may reduce the reluctance of some PCPs to
prescribe insulin even when the treatment guidelines would indicate
a patient requires insulin. Finally, the remote
monitoring feature of ALRT’s Health-e-Connect system may lessen the
very real problem of insulin non-adherence and non-persistence by
many patients. ALRT’s Diabetes Care Facilitators (DCFs)
will be trained on physician-approved protocols to recognize
non-adherence in the patient blood glucose trends so the DCFs can
then arrange a care intervention without waiting for the next
physician visit by the patient.
“We think that many primary care physicians will welcome a
near-effortless consultation on their insulin doses from such a
respected expert in diabetes,” commented Sidney Chan, Chief
Executive Officer of ALR Technologies. “We are honored to
partner with Dr. Davidson who will be an invaluable resource to
these physicians.”
Dr. Mayer B. Davidson added: “The reality is that many
physicians do not have the time to regularly adjust the patient’s
dose to achieve optimal glucose control, while other physicians are
concerned about writing an insulin prescription because of the
potential adverse events that could flow from an improper
dose. ALRT’s technology will allow me to assist many
physicians with these challenges and to bring intensive blood
glucose control to many more patients. This is a win for
patients and a win for the healthcare system through more intensive
management of diabetes.”
A video explaining the new platform can be found here: http://youtu.be/rRxEKUE4tkA
About Dr. Mayer B. Davidson
Dr. Davidson has published numerous academic studies on insulin and
insulin resistance, including a recent study in the American
Journal of Managed Care in which a group of patients with
diabetes saw their A1C levels drop from 11.1% to 7.2% through more
careful, and more regular, management of their medication. (See:
American Journal of Managed Care Volume 16, pages 652-656, 2010)
Dr. Davidson is Professor of Medicine at both the David
Geffen School of Medicine at UCLA and Charles R. Drew University.
Dr. Davidson was President of the American Diabetes Association in
1997-1998. A renowned researcher and speaker on type 2 diabetes and
insulin resistance, Dr. Davidson has presented hundreds of lectures
nationally and internationally. He has served on the Editorial
Boards of Diabetes Care, Diabetes Spectrum, Clinical
Diabetes, Diabetes Reports, Today in Medicine,
Geriatrics and the Journal of Clinical
Endocrinology and Metabolism and was a Consulting
Editor of Hippocrates and an Associate
Editor of Endo Trends. He currently
serves on the Editorial Board of Diabetes Research
& Clinical Practice. Further, Dr. Davidson was
the Founding Editor of Current Diabetes
Reports and was the Editor-in-Chief of
Diabetes Care from 2002 through 2006, the
leading clinical journal for the diabetes community. Dr. Davidson’s
contributions to the medical literature include 3 books on diabetes
care, 168 scientific papers, 31 book chapters, 59 reviews and 54
editorials and invited articles.
About ALR Technologies
Inc.
ALR Technologies is a medical device company providing remote
monitoring and care facilitation for patients with chronic
diseases. ALRT has developed the FDA-cleared and HIPAA compliant
Health-e-Connect System that collects data from blood glucose
meters and uploads to a secure website. Trained Facilitators use
the System to effect efficiency of care among patients, clinicians
and caregivers to improve outcomes and assist health plans to
optimize their quality goals. Currently, the Company is focused on
diabetes and will expand its services to cover other chronic
diseases anchored on verifiable data. More information about ALR
Technologies, Inc. can be found at www.alrt.com.
ALR Technologies is active in providing articles, videos and
information on diabetes via social media. ALR Technologies
can be found on Facebook at: https://www.facebook.com/ALRTechnologies and on
Twitter at: https://twitter.com/ALRTechnologies.
Contact: Philip Murphy:
203.947.2827
email: phil.murphy@alrt.com
This release contains certain "forward-looking statements" relating
to ALR Technologies' business, and these statements reflect the
current views of ALR Technologies with respect to future events and
are subject to certain risks, uncertainties and assumptions. When
used, the words "estimate", "expect", "anticipate", "believe" and
similar expressions are intended to identify such forward-looking
statements. There are many factors that could cause the actual
results, performance or achievements of ALR Technologies and its
products to be materially different from any future results,
performances or achievements that may be expressed or implied by
such forward-looking statements. Further management discussions of
risks and uncertainties can be found in the company's quarterly
filings with the Securities Exchange.
ALR Technologies (QB) (USOTC:ALRT)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
ALR Technologies (QB) (USOTC:ALRT)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about ALR Technologies Inc (QB) (OTCMarkets): 0 recent articles
Plus d'articles sur Alr Technologies, Inc. (QB)